These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12746099)

  • 1. Extracorporeal shockwave therapy for peyronie disease.
    Groth T; Monga M
    Arch Androl; 2003; 49(3):205-13. PubMed ID: 12746099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term results of extracorporeal shockwave therapy for Peyronie's disease.
    Srirangam SJ; Manikandan R; Hussain J; Collins GN; O'Reilly PH
    J Endourol; 2006 Nov; 20(11):880-4. PubMed ID: 17144855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal shockwave therapy for Peyronie's disease does not correct penile deformity.
    Strebel RT; Suter S; Sautter T; Hauri D
    Int J Impot Res; 2004 Oct; 16(5):448-51. PubMed ID: 14973523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of extracorporeal shockwave therapy in andrology].
    Qin X; Lu YP
    Zhonghua Nan Ke Xue; 2012 Dec; 18(12):1125-9. PubMed ID: 23405798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal shockwave therapy for Peyronie's disease: an alternative treatment?
    Poulakis V; Skriapas K; de Vries R; Dillenburg W; Ferakis N; Witzsch U; Melekos M; Becht E
    Asian J Androl; 2006 May; 8(3):361-6. PubMed ID: 16625288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An alternative non-invasive treatment for Peyronie's disease.
    Claro JA; Passerotti CC; Figueiredo Neto AC; Nardozza A; Ortiz V; Srougi M
    Int Braz J Urol; 2004; 30(3):199-204; discussion 204. PubMed ID: 15689246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Peyronie's disease by extracorporeal shockwave therapy: evaluation of our preliminary results.
    Abdel-Salam Y; Budair Z; Renner C; Frede T; Rassweiler J; El-Annany F; El-Magraby H; El-Akkad M
    J Endourol; 1999 Oct; 13(8):549-52. PubMed ID: 10597123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indications and application of extracorporeal shockwave therapy].
    Skov-Jeppesen SM; Lundrup RN; Ladegaard PBJ; Mortensen J; Sørensen MD; Lund L
    Ugeskr Laeger; 2019 Feb; 181(8):. PubMed ID: 30821242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal shockwave therapy for Peyronie's disease: who benefits?
    Taylor J; Forster JA; Browning AJ; Biyani CS
    J Endourol; 2006 Feb; 20(2):135-8. PubMed ID: 16509800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Extracorporeal shock-wave therapy in Peyronie's disease].
    Aboian IA; Mitusov VV; Pakus OI; Grachev SV; Pavlov SV; Shestel' AN
    Urologiia; 2004; (5):39-42. PubMed ID: 15560161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of extracorporeal shock-wave therapy (ESWT) in plastic penile induration. Statement of the DGU].
    Weidner W; Hauck EW
    Urologe A; 2004 May; 43(5):597-8. PubMed ID: 15107976
    [No Abstract]   [Full Text] [Related]  

  • 12. Extracorporeal shock wave therapy in the treatment of Peyronie's disease: experience with standard lithotriptor (siemens-multiline).
    Lebret T; Loison G; Hervé JM; Mc Eleny KR; Lugagne PM; Yonneau L; Orsoni JL; Saporta F; Butreau M; Botto H
    Urology; 2002 May; 59(5):657-61. PubMed ID: 11992835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peyronie's disease-the Plymouth experience of extracorporeal shockwave treatment.
    Hamm R; McLarty E; Ashdown J; Natale S; Dickinson A
    BJU Int; 2001 Jun; 87(9):849-52. PubMed ID: 11412225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal shock wave therapy in Peyronie's disease: results of a placebo-controlled, prospective, randomized, single-blind study.
    Hatzichristodoulou G; Meisner C; Gschwend JE; Stenzl A; Lahme S
    J Sex Med; 2013 Nov; 10(11):2815-21. PubMed ID: 23898925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal shock wave therapy for Peyronie's disease: exploratory meta-analysis of clinical trials.
    Hauck EW; Mueller UO; Bschleipfer T; Schmelz HU; Diemer T; Weidner W
    J Urol; 2004 Feb; 171(2 Pt 1):740-5. PubMed ID: 14713800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Questionable efficacy of extracorporeal shock wave therapy for Peyronie's disease: results of a prospective approach.
    Hauck EW; Hauptmann A; Bschleipfer T; Schmelz HU; Altinkilic BM; Weidner W
    J Urol; 2004 Jan; 171(1):296-9. PubMed ID: 14665898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary findings from a new animal model for Peyronie's disease involving extracorporeal shock waves.
    Andrade E; Cortez I; Claro J; Pompeu E; Leite K; Paranhos M; Borra P; Lucon AM; Srougi M
    BJU Int; 2009 Apr; 103(8):1104-6. PubMed ID: 19021616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focused extracorporeal shockwave therapy in Dupuytren's disease--a hypothesis.
    Knobloch K; Kuehn M; Vogt PM
    Med Hypotheses; 2011 May; 76(5):635-7. PubMed ID: 21277691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsurgical interventions for Peyronie disease: 2011 update.
    Schaeffer AJ; Burnett AL
    J Androl; 2012; 33(1):3-14. PubMed ID: 21350241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary Thoughts on the Role of Shockwave Therapy in Peyronie's Disease.
    Fode M; Østergren PB
    J Sex Med; 2020 Feb; 17(2):174-179. PubMed ID: 31992436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.